Media Center

Press releases

COVID-19 outbreak: Alfasigma donates over 100.000 euros to Romanian Hospitals

Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis

Alfasigma USA Acquires Zelnorm™

Alfasigma SpA – Corporate announcement

Alfasigma expands its footprint in the U.S. through the acquisition of Pamlab from Nestle health science

Alfasigma is born the new italian pharmaceutical entity with strong international presence

Press release archive

Multimedia

Social Wall

Press coverage

Alfasigma USA Reintroduces IBS-C Drug Zelnorm to U.S. Market

Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Devel...

Interview with Stefano Golinelli by Margherita Lopes - Adnkronos Salute’s PharmaKronos

Press coverage archive